238 related articles for article (PubMed ID: 26041846)
21. Quantitative proteomics study of breast cancer cell lines isolated from a single patient: discovery of TIMM17A as a marker for breast cancer.
Xu X; Qiao M; Zhang Y; Jiang Y; Wei P; Yao J; Gu B; Wang Y; Lu J; Wang Z; Tang Z; Sun Y; Wu W; Shi Q
Proteomics; 2010 Apr; 10(7):1374-90. PubMed ID: 20198662
[TBL] [Abstract][Full Text] [Related]
22. The Challenge of Classifying Metastatic Cell Properties by Molecular Profiling Exemplified with Cutaneous Melanoma Cells and Their Cerebral Metastasis from Patient Derived Mouse Xenografts.
Neuditschko B; Janker L; Niederstaetter L; Brunmair J; Krivanek K; Izraely S; Sagi-Assif O; Meshel T; Keppler BK; Del Favero G; Witz IP; Gerner C
Mol Cell Proteomics; 2020 Mar; 19(3):478-489. PubMed ID: 31892524
[TBL] [Abstract][Full Text] [Related]
23. miRNA and Proteomic Dysregulation in Non-Small Cell Lung Cancer in Response to Cigarette Smoke.
Babu N; Advani J; Solanki HS; Patel K; Jain A; Khan AA; Radhakrishnan A; Sahasrabuddhe NA; Mathur PP; Nair B; Keshava Prasad TS; Chang X; Sidransky D; Gowda H; Chatterjee A
Microrna; 2018; 7(1):38-53. PubMed ID: 29299995
[TBL] [Abstract][Full Text] [Related]
24. T lymphocytes facilitate brain metastasis of breast cancer by inducing Guanylate-Binding Protein 1 expression.
Mustafa DAM; Pedrosa RMSM; Smid M; van der Weiden M; de Weerd V; Nigg AL; Berrevoets C; Zeneyedpour L; Priego N; Valiente M; Luider TM; Debets R; Martens JWM; Foekens JA; Sieuwerts AM; Kros JM
Acta Neuropathol; 2018 Apr; 135(4):581-599. PubMed ID: 29350274
[TBL] [Abstract][Full Text] [Related]
25. Integrated proteotranscriptomics of breast cancer reveals globally increased protein-mRNA concordance associated with subtypes and survival.
Tang W; Zhou M; Dorsey TH; Prieto DA; Wang XW; Ruppin E; Veenstra TD; Ambs S
Genome Med; 2018 Dec; 10(1):94. PubMed ID: 30501643
[TBL] [Abstract][Full Text] [Related]
26. Determination of the protein expression profiles of breast cancer cell lines by quantitative proteomics using iTRAQ labelling and tandem mass spectrometry.
Calderón-González KG; Valero Rustarazo ML; Labra-Barrios ML; Bazán-Méndez CI; Tavera-Tapia A; Herrera-Aguirre ME; Sánchez del Pino MM; Gallegos-Pérez JL; González-Márquez H; Hernández-Hernández JM; León-Ávila G; Rodríguez-Cuevas S; Guisa-Hohenstein F; Luna-Arias JP
J Proteomics; 2015 Jun; 124():50-78. PubMed ID: 25918110
[TBL] [Abstract][Full Text] [Related]
27. Her-2 overexpression increases the metastatic outgrowth of breast cancer cells in the brain.
Palmieri D; Bronder JL; Herring JM; Yoneda T; Weil RJ; Stark AM; Kurek R; Vega-Valle E; Feigenbaum L; Halverson D; Vortmeyer AO; Steinberg SM; Aldape K; Steeg PS
Cancer Res; 2007 May; 67(9):4190-8. PubMed ID: 17483330
[TBL] [Abstract][Full Text] [Related]
28. New insights into the roles of the
Mayahi S; Golalipour M; Yamchi A; Jhingan GD; Shahbazi M
Ups J Med Sci; 2019 Aug; 124(3):149-157. PubMed ID: 31294654
[No Abstract] [Full Text] [Related]
29. Novel breast cancer biomarkers identified by integrative proteomic and gene expression mapping.
Ou K; Yu K; Kesuma D; Hooi M; Huang N; Chen W; Lee SY; Goh XP; Tan LK; Liu J; Soon SY; Bin Abdul Rashid S; Putti TC; Jikuya H; Ichikawa T; Nishimura O; Salto-Tellez M; Tan P
J Proteome Res; 2008 Apr; 7(4):1518-28. PubMed ID: 18318472
[TBL] [Abstract][Full Text] [Related]
30. [Differential expression of secretagogin and glucose-related protein 78 in colorectal carcinoma: a proteome study].
Xing XM; Wang YH; Huang Q; Lü BJ; Lai MD
Zhonghua Bing Li Xue Za Zhi; 2007 Feb; 36(2):107-12. PubMed ID: 17493385
[TBL] [Abstract][Full Text] [Related]
31. ADAM22/LGI1 complex as a new actionable target for breast cancer brain metastasis.
Charmsaz S; Doherty B; Cocchiglia S; Varešlija D; Marino A; Cosgrove N; Marques R; Priedigkeit N; Purcell S; Bane F; Bolger J; Byrne C; O'Halloran PJ; Brett F; Sheehan K; Brennan K; Hopkins AM; Keelan S; Jagust P; Madden S; Martinelli C; Battaglini M; Oesterreich S; Lee AV; Ciofani G; Hill ADK; Young LS
BMC Med; 2020 Nov; 18(1):349. PubMed ID: 33208158
[TBL] [Abstract][Full Text] [Related]
32. Expression of LC3B and FIP200/Atg17 in brain metastases of breast cancer.
Hashemi-Sadraei N; Müller-Greven GM; Abdul-Karim FW; Ulasov I; Downs-Kelly E; Burgett ME; Lauko A; Qadan MA; Weil RJ; Ahluwalia MS; Du L; Prayson RA; Chao ST; Budd TG; Barnholtz-Sloan J; Nowacki AS; Keri RA; Gladson CL
J Neurooncol; 2018 Nov; 140(2):237-248. PubMed ID: 30094720
[TBL] [Abstract][Full Text] [Related]
33. Molecular Pathways Mediating Metastases to the Brain via Epithelial-to-Mesenchymal Transition: Genes, Proteins, and Functional Analysis.
Jeevan DS; Cooper JB; Braun A; Murali R; Jhanwar-Uniyal M
Anticancer Res; 2016 Feb; 36(2):523-32. PubMed ID: 26851006
[TBL] [Abstract][Full Text] [Related]
34. Insulin like growth factor binding protein-7 reduces growth of human breast cancer cells and xenografted tumors.
Amemiya Y; Yang W; Benatar T; Nofech-Mozes S; Yee A; Kahn H; Holloway C; Seth A
Breast Cancer Res Treat; 2011 Apr; 126(2):373-84. PubMed ID: 20464481
[TBL] [Abstract][Full Text] [Related]
35. Long Noncoding RNA GMAN, Up-regulated in Gastric Cancer Tissues, Is Associated With Metastasis in Patients and Promotes Translation of Ephrin A1 by Competitively Binding GMAN-AS.
Zhuo W; Liu Y; Li S; Guo D; Sun Q; Jin J; Rao X; Li M; Sun M; Jiang M; Xu Y; Teng L; Jin Y; Si J; Liu W; Kang Y; Zhou T
Gastroenterology; 2019 Feb; 156(3):676-691.e11. PubMed ID: 30445010
[TBL] [Abstract][Full Text] [Related]
36. Elevated nuclear S100P expression is associated with poor survival in early breast cancer patients.
Maciejczyk A; Łacko A; Ekiert M; Jagoda E; Wysocka T; Matkowski R; Hałoń A; Györffy B; Lage H; Surowiak P
Histol Histopathol; 2013 Apr; 28(4):513-24. PubMed ID: 23364898
[TBL] [Abstract][Full Text] [Related]
37. Identification of lipid biomarkers of metastatic potential and gene expression (HER2/p53) in human breast cancer cell cultures using ambient mass spectrometry.
Robison HM; Chini CE; Comi TJ; Ryu SW; Ognjanovski E; Perry RH
Anal Bioanal Chem; 2020 May; 412(12):2949-2961. PubMed ID: 32322955
[TBL] [Abstract][Full Text] [Related]
38. Integrated genomic and transcriptomic analysis of human brain metastases identifies alterations of potential clinical significance.
Saunus JM; Quinn MC; Patch AM; Pearson JV; Bailey PJ; Nones K; McCart Reed AE; Miller D; Wilson PJ; Al-Ejeh F; Mariasegaram M; Lau Q; Withers T; Jeffree RL; Reid LE; Da Silva L; Matsika A; Niland CM; Cummings MC; Bruxner TJ; Christ AN; Harliwong I; Idrisoglu S; Manning S; Nourse C; Nourbakhsh E; Wani S; Anderson MJ; Fink JL; Holmes O; Kazakoff S; Leonard C; Newell F; Taylor D; Waddell N; Wood S; Xu Q; Kassahn KS; Narayanan V; Taib NA; Teo SH; Chow YP; kConFab ; Jat PS; Brandner S; Flanagan AM; Khanna KK; Chenevix-Trench G; Grimmond SM; Simpson PT; Waddell N; Lakhani SR
J Pathol; 2015 Nov; 237(3):363-78. PubMed ID: 26172396
[TBL] [Abstract][Full Text] [Related]
39. microRNAs Orchestrate Pathophysiology of Breast Cancer Brain Metastasis: Advances in Therapy.
Kanchan RK; Siddiqui JA; Mahapatra S; Batra SK; Nasser MW
Mol Cancer; 2020 Feb; 19(1):29. PubMed ID: 32059676
[TBL] [Abstract][Full Text] [Related]
40. ATF-3/miR-590/GOLPH3 signaling pathway regulates proliferation of breast cancer.
Song Q; Chen Q; Wang Q; Yang L; Lv D; Jin G; Liu J; Li B; Fei X
BMC Cancer; 2018 Mar; 18(1):255. PubMed ID: 29534690
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]